This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
LL-37 is the only known human cathelicidin antimicrobial peptide, derived from the C-terminus of the human CAP18 protein. It is produced by epithelial cells, neutrophils, macrophages, and NK cells in response to infection and inflammation.
LL-37 disrupts bacterial cell membranes through electrostatic interactions with anionic phospholipids, forming pores that lead to membrane disintegration โ effective against gram-positive, gram-negative bacteria, and fungi. It also modulates innate immunity by acting as a chemokine for neutrophil and monocyte recruitment, activating Toll-like receptor signaling, and inducing angiogenesis. Anti-cancer activity may involve direct tumor cell membrane disruption and immune activation.
LL-37 disrupts bacterial cell membranes through electrostatic interactions with anionic phospholipids, forming pores that lead to membrane disintegration โ effective against gram-positive, gram-negative bacteria, and fungi. It also modulates innate immunity by acting as a chemokine for neutrophil and monocyte recruitment, activating Toll-like receptor signaling, and inducing angiogenesis. Anti-cancer activity may involve direct tumor cell membrane disruption and immune activation.
LL-37 is the only known human cathelicidin antimicrobial peptide, derived from the C-terminus of the human CAP18 protein. It is produced by epithelial cells, neutrophils, macrophages, and NK cells in response to infection and inflammation. Research spans antimicrobial applications, wound healing, immunomodulation, and potential anti-cancer properties.
IUPAC Name
Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys... (37 amino acid sequence)
CAS Number
154947-66-7
Molecular Formula
C205H340N60O53S
Molecular Mass
4493.4 g/mol
Create a free account to:
Join 2,800+ researchers
Create a free account to:
Join 2,800+ researchers
Known autoimmune conditions (may exacerbate immune response). Pregnancy or breastfeeding. Active systemic infection requiring specific antimicrobials.
Research Disclaimer
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
No listings found for LL-37.
3013 PubMed studies
Data Completeness
75%Research Credibility
Well-researched compound
Molecular Weight
4493.4 g/mol
CAS Number
154947-66-7
Trial Phase
Phase 2
Common Side Effects
Stop Use If
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
LL-37 is the only known human cathelicidin antimicrobial peptide, derived from the C-terminus of the human CAP18 protein. It is produced by epithelial cells, neutrophils, macrophages, and NK cells in response to infection and inflammation. Research spans antimicrobial applications, wound healing, immunomodulation, and potential anti-cancer properties.
LL-37 is available in vials, capsules, and sprays forms.
Pricing varies by vendor and form.
Compare prices, payment methods, shipping, and COA scores across 0 vendors.